Rising Demand for Early Autoimmune Diagnosis Boosts the Antinuclear Antibody Test Market The Antinuclear Antibody Test Market was valued at USD 1,690.27 million in 2024, and it is projected to grow at an impressive CAGR of 13.60% from 2025 to 2032. This significant expansion reflects the growing need for accurate diagnostic tools to detect autoimmune diseases, which have become an increasing...